Science & Medicine
Celera president says misinformation was spread by rival group about the private company’s bid to control the research.
March 8, 2000
J.
Jan. 23, 2002
Biotech: The two leaders plan to issue joint statement that data on human genome should be public, not private, property.
March 14, 2000
Biotech: Company says it expects to have a ‘rough draft’ of human genome by early summer. Lucrative drug role is at stake.
Jan. 11, 2000
Business
General Electric Co. said it was teaming up with Celera Genomics Group, the company that spearheaded the mapping of the human genome, to develop diagnostic tools that can speed drug research and help identify patients who are likely to respond to particular therapies.
July 13, 2004
No wonder so much of the “new economy” seems like a fad.
Oct. 15, 2000
Science: Some human genetic data were included. It fans the acrimony between public and private efforts.
April 20, 2000
DNA: Biotech company reports huge gains in decoding human blueprint and seeks protection for 6,500 of its finds. Move raises fears that medical advances could be slowed if science is kept in private hands.
Oct. 24, 1999
World & Nation
Celera Genomics and the publicly funded Human Genome Project said Friday that they had finished making arrangements for a joint announcement on mapping the human genome.
June 24, 2000
Biotech: Public group will submit its findings to another publication to protest Celera’s restricted disclosure agreement.
Dec. 13, 2000